SCHEMBL17867723

SCHEMBL17867723

OC1C[C@H](O)[C@@H](OCc2ccccc2)[C@@H](COCc2ccccc2)O1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 1/20 0.50
GJB2 P29033 3/20 0.49
HTR1A P08908 1/20 0.46
NT5E P21589 1/20 0.45
BCHE P06276 1/20 0.45
ACHE P22303 1/20 0.45
TACR2 P21452 3/20 0.44
GJA1 P17302 1/20 0.42
PTPN1 P18031 3/20 0.42
PTPN2 P17706 1/20 0.42
PTPN11 Q06124 1/20 0.42
SLC6A2 P23975 1/20 0.41
SSTR1 P30872 1/20 0.41
SSTR2 P30874 1/20 0.41
SSTR4 P31391 1/20 0.41
SSTR3 P32745 1/20 0.41
SSTR5 P35346 1/20 0.41
CDC25B P30305 2/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17867724 1.00 PDE4D (0.50) PDE4DGJB2HTR1ANT5EBCHE
SCHEMBL18542094 0.88 PDE4D (0.52) PDE4DGJB2HTR1ANT5EBCHE
SCHEMBL22754536 0.88 PDE4D (0.52) PDE4DGJB2HTR1ANT5EBCHE
SCHEMBL18868663 0.88 PDE4D (0.52) PDE4DGJB2HTR1ANT5EBCHE
SCHEMBL11424925 0.88 PDE4D (0.52) PDE4DGJB2HTR1ANT5EBCHE
SCHEMBL24725536 0.88 PDE4D (0.52) PDE4DGJB2HTR1ANT5EBCHE
SCHEMBL17867767 0.88 PDE4D (0.52) PDE4DGJB2HTR1ANT5EBCHE
SCHEMBL17867766 0.88 PDE4D (0.52) PDE4DGJB2HTR1ANT5EBCHE
SCHEMBL18639181 0.88 PDE4D (0.52) PDE4DGJB2HTR1ANT5EBCHE
SCHEMBL18542505 0.88 PDE4D (0.52) PDE4DGJB2HTR1ANT5EBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11925654-B2 Esters of 2-deoxy-monosaccharides with anti proliferative activity BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2024-03-12 US disclosed
US-20220023326-A1 ESTERS OF 2-DEOXY-MONOSACCHARIDES WITH ANTI PROLIFERATIVE ACTIVITY UNIV TEXAS (US) 2022-01-27 US disclosed
EP-3939595-A1 ESTERS OF 2-DEOXY-MONOSACCHARIDES WITH ANTI PROLIFERATIVE ACTIVITY Board of Regents, The University of Texas System (US) 2022-01-19 EP disclosed
US-11026960-B2 Esters of 2-deoxy-monosaccharides with anti proliferative activity BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2021-06-08 US disclosed
US-20190224225-A1 ESTERS OF 2-DEOXY-MONOSACCHARIDES WITH ANTI PROLIFERATIVE ACTIVITY BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2019-07-25 US disclosed
US-10201554-B2 Esters of 2-deoxy-monosacharides with anti proliferative activity BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2019-02-12 US disclosed
US-20160184336-A1 ESTERS OF 2-DEOXY-MONOSACHARIDES WITH ANTI PROLIFERATIVE ACTIVITY BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10201554-B2 Esters of 2-deoxy-monosacharides with anti proliferative activity DERA, G6PD, HK2 PDE4D 2119/4885GJB2 4484/4885HTR1A 3930/4885
US-11925654-B2 Esters of 2-deoxy-monosaccharides with anti proliferative activity SLC2A2, SLC2A1, SLC2A4 PDE4D 2417/4885GJB2 4808/4885HTR1A 4091/4885
US-20190224225-A1 ESTERS OF 2-DEOXY-MONOSACCHARIDES WITH ANTI PROLIFERATIVE ACTIVITY SLC2A2, SLC2A1, SLC2A4 PDE4D 2417/4885GJB2 4808/4885HTR1A 4091/4885
US-11026960-B2 Esters of 2-deoxy-monosaccharides with anti proliferative activity SLC2A2, SLC2A1, SLC2A4 PDE4D 2417/4885GJB2 4808/4885HTR1A 4091/4885
US-20160184336-A1 ESTERS OF 2-DEOXY-MONOSACHARIDES WITH ANTI PROLIFERATIVE ACTIVITY DERA, G6PD, HK2 PDE4D 2119/4885GJB2 4484/4885HTR1A 3930/4885
US-20220023326-A1 ESTERS OF 2-DEOXY-MONOSACCHARIDES WITH ANTI PROLIFERATIVE ACTIVITY SLC2A2, SLC2A1, SLC2A4 PDE4D 2417/4885GJB2 4808/4885HTR1A 4091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.